India-US trade pact talks may gather pace only after Section 301 excess capacity findings
The outcome of a US Section 301 investigation into forced-labour import enforcement has been settled, with India placed in a lower tariff tier, removing one source of uncertainty from bilateral trade discussions
A separate, still-pending US Section 301 investigation into "structural excess capacity and production" in manufacturing sectors covering 16 economies, including India, has not yet produced its findings or a proposed remedy
Momentum on the broader India-US Bilateral Trade Agreement (BTA) negotiations is understood to depend significantly on the direction and scope of this pending excess-capacity determination
Officials indicated that talks on the comprehensive trade pact are continuing in parallel but that a clearer sense of pace will likely emerge only once the excess-capacity findings, and any resulting tariff proposals, are made public
Section 301 of the US Trade Act, 1974 — the excess-capacity track
Section 301 authorises the US Trade Representative (USTR) to investigate and act unilaterally against a foreign country's acts, policies, or practices judged "unreasonable" or discriminatory and burdensome to US commerce, without requiring a prior WTO dispute ruling. The excess-capacity investigation is a separate Section 301 track from the forced-labour probe, examining whether structural overcapacity in a country's manufacturing sectors (steel, chemicals, EVs, solar cells, etc.) is depressing global prices and displacing US production.
Key Details
- Initiated on March 11, 2026, covering 16 economies: China, the EU, India, Japan, Korea, Indonesia, Malaysia, Singapore, Switzerland, Norway, Taiwan, Thailand, Vietnam, Bangladesh, Cambodia and Mexico
- A public docket opened March 17, 2026; written comments closed April 15, 2026; USTR held a public hearing on May 5, 2026
- USTR and the US administration had set July 24, 2026 as a target date for completing the investigation and any remedy determination, though findings for India remain undisclosed as of this report
- Runs independently of, but in parallel with, the separate Section 301 forced-labour investigation into the same set of economies, which concluded earlier with tariff tiers of 10% and 12.5%
Because the excess-capacity probe's findings and remedy (if any) are still pending, India-US BTA negotiators cannot fully price in the tariff landscape until USTR's determination is published — explaining why sources link the pace of pact talks to this specific investigation rather than the now-resolved forced-labour one.
"Structural excess capacity" as a trade-remedy concept
Structural excess capacity refers to a sustained gap between an economy's production capacity in a sector and the demand it can absorb domestically, with the surplus routed to export markets — often at prices below the cost of production in importing countries. It is distinct from ordinary anti-dumping or countervailing-duty findings because it targets systemic industrial policy (subsidies, cheap credit, land, and energy) rather than a single instance of pricing below "normal value."
Key Details
- Anti-dumping and countervailing-duty (CVD) actions are transaction-specific and governed multilaterally by the WTO's Agreement on Anti-Dumping and the Agreement on Subsidies and Countervailing Measures (SCM Agreement)
- Section 301 excess-capacity findings, by contrast, are a unilateral US determination not tied to a specific WTO agreement, giving USTR wider discretion on remedies (tariffs, quotas, or negotiated commitments)
- India's own trade-remedy apparatus for dumped or subsidised imports is the Directorate General of Trade Remedies (DGTR, formed 2018), which recommends anti-dumping/CVD/safeguard duties to the Ministry of Finance
- The WTO's Agreement on Safeguards (under GATT Article XIX) allows emergency, non-discriminatory import restrictions where a surge of imports causes "serious injury" to a domestic industry — a multilateral analogue India itself has invoked in select sectors (e.g., steel)
If USTR's excess-capacity findings implicate specific Indian manufacturing sectors, any resulting US tariff action would sit outside WTO dispute-settlement disciplines, adding a variable that a comprehensive BTA would need to separately address or carve around.
India-US Bilateral Trade Agreement (BTA) negotiation track
India and the US launched negotiations for a comprehensive Bilateral Trade Agreement on February 13, 2025, with an interim framework announced via joint statement on February 7, 2026, that lowered the US "reciprocal tariff" on Indian goods from 25% to 18% and secured Indian market-access commitments on select US agricultural and industrial goods.
Key Details
- The February 2026 interim framework explicitly commits both sides to conclude a broader BTA covering market access, tariff-rate quotas (including on automotive parts), and unresolved sector-specific issues such as textiles
- The BTA track runs alongside, but is legally distinct from, the Section 301 forced-labour and excess-capacity tracks — each is a separate US legal instrument with its own investigation and remedy process
- Because Section 301 actions are unilateral executive determinations rather than negotiated tariff lines, they can be announced independently of, and potentially disrupt, the calendar for BTA negotiations
The article's core point — that BTA talks "may gather pace only after" the excess-capacity findings — reflects how a still-open unilateral US investigation can act as a gating factor on a parallel bilateral negotiation, even though the two processes are formally separate.
- Section 301 excess-capacity investigation initiated: March 11, 2026, covering 16 economies including India
- USTR target date for completing the excess-capacity investigation: July 24, 2026 (findings for India not yet public as of this report)
- Section 301 forced-labour investigation (resolved, separate track): initiated March 12, 2026, covering 60 economies; India placed in the 10% additional-tariff tier versus a 12.5% tier for others
- India-US BTA negotiations launched: February 13, 2025
- Interim trade framework announced: February 7, 2026; cut the US reciprocal tariff on Indian goods from 25% to 18%
- India's domestic trade-remedy authority: Directorate General of Trade Remedies (DGTR), established 2018